Skip to content

Innovative Strategies to Increase the use of Biosimilars and Lower Prescription Drug Costs

Share

In a recent episode of The Pharmacy Benefit podcast, Pharmaceutical Care Management Association (PCMA) President and CEO, JC Scott, was joined by two executives of Prime Therapeutics, Dr. Joseph Leach, Senior Vice President and Chief Medical Officer, along with Jarrod Henshaw, Senior Vice President and Innovation & Supply Chain Officer, to discuss the value of biosimilars. Prime Therapeutics recently launched MedDrive, a program that, in part, looks at greater biosimilar adoption. They discuss increasing the use of biosimilars by implementing innovative strategies that increase competition and lower prescription drug costs for patients.

To hear JC Scott, Dr. Leach, and Jarrod Henshaw’s entire conversation and learn more about innovative strategies to increase the use of biosimilars and lower drug costs for patients, check out the latest episode of the Pharmacy Benefit Podcast here.

Stay up to date on your health care savings.

Get updates and more information on how PBMs are lowering your prescription drug costs and coordinating your health care by subscribing below.

pills

Show you care!

Pharmacy benefit managers (PBMs) are your advocates in the health care system, working to lower out-of-control prescription drug costs for patients across the country.

Scroll To Top